New Trends in Cancer for the 21st Century
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2006.
|
| Edition: | 2nd ed. 2006. |
| Series: | Advances in Experimental Medicine and Biology,
587 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-1-4020-5133-3 |
Table of Contents:
- Prognostic and Therapeutic Targets in the Ewing's Family of Tumors (PROTHETS)
- Targeted Therapies in Ewing's Sarcoma
- The CCN3 Protein and Cancer
- Ews-Fli1 in Ewing's Sarcoma: Real Targets and Collateral Damage
- Molecular Karyotyping in Sarcoma Diagnostics and Research
- TuBaFrost: European Virtual Tumor Tissue Banking
- Virtual Microscopy in Virtual Tumor Banking
- Harmonizing Cancer Control in Europe
- The Diagnosis of Cancer: "From H&E to Molecular Diagnosis and Back"
- From Morphological to Molecular Diagnosis of Soft Tissue Tumors
- Prediction of Response to Neoadjuvant Chemotherapy in Carcinomas of the Upper Gastrointestinal Tract
- Integrating the Diagnosis of Childhood Malignancies
- Preclinical Models for Cell Cycle-Targeted Therapies
- WWOX, a Chromosomal Fragile Site Gene and its Role in Cancer
- From Genome to Proteome in Tumor Profiling: Molecular Events in Colorectal Cancer Genesis
- Effect of Hypoxia on the Tumor Phenotype: The Neuroblastoma and Breast Cancer Models
- Methylation Patterns and Chemosensitivity in NSCLC
- Pharmacogenomics and Colorectal Cancer
- Development of Pharmacogenomic Predictors for Preoperative Chemotherapy of Breast Cancer
- Vascular Endothelial Growth Factor Inhibitors in Colon Cancer
- Molecular Imaging of Cancer Using PET and SPECT
- MRS as Endogenous Molecular Imaging for Brain and Prostate Tumors: FP6 Project "eTUMOR"
- From Linac to Tomotherapy: New Possibilities for Cure?
- Targeting mTOR for Cancer Treatment
- Dual/Pan-Her Tyrosine Kinase Inhibitors: Focus in Breast Cancer
- AntiTumor-Associated Antigens IGGS: Dual Positive and Negative Potential Effects for Cancer Therapy
- Synergistic Molecular Mechanisms in Hormone-Sensitive Breast Cancer.